Cargando…
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception
BACKGROUND AND OBJECTIVES: In women with highly active multiple sclerosis (MS), suspending rituximab (RTX) for planning pregnancy is associated with low disease reactivation. Whether this strategy reduces the risk of disease reactivity as compared with suspending natalizumab (NTZ) 3 months after con...
Autores principales: | Demortiere, Sarah, Maarouf, Adil, Rico, Audrey, Boutiere, Clemence, Hilezian, Frederic, Durozard, Pierre, Pelletier, Jean, Audoin, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406425/ https://www.ncbi.nlm.nih.gov/pubmed/37550074 http://dx.doi.org/10.1212/NXI.0000000000200161 |
Ejemplares similares
-
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
por: Claverie, Roxane, et al.
Publicado: (2023) -
Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
por: Maarouf, Adil, et al.
Publicado: (2020) -
Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
por: Perriguey, Marine, et al.
Publicado: (2021) -
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021) -
Determining the best window for BNT162b2 mRNA vaccination for
SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20
therapy
por: Rico, Audrey, et al.
Publicado: (2021)